Cloud-clone
SKU:AEA012Hu
ELISA Kit for Anti-S100 Calcium Binding Protein Antibody (Anti-S100)
ELISA Kit for Anti-S100 Calcium Binding Protein Antibody (Anti-S100)
Couldn't load pickup availability
Enzyme-linked immunosorbent assay for Antibody Detection.
Product No.
AEA012Hu
Organism Species
Homo sapiens (Human).
Sample Type
serum, plasma and other biological fluids
Test Method
Indirect ELISA
Assay Length
2h, 30min
Detection Range
3.12-200ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 1.24ng/mL.
UOM
48T 96T 96T*5 96T*10 96T*100
Specificity
This assay has high sensitivity and excellent specificity for detection of Anti-S100 Calcium Binding Protein Antibody (Anti-S100).
No significant cross-reactivity or interference between Anti-S100 Calcium Binding Protein Antibody (Anti-S100) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of Anti-S100 Calcium Binding Protein Antibody (Anti-S100) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-S100 Calcium Binding Protein Antibody (Anti-S100) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 96-105 | 101 |
| EDTA plasma(n=5) | 85-101 | 91 |
| heparin plasma(n=5) | 93-101 | 97 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-S100 Calcium Binding Protein Antibody (Anti-S100) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-S100 Calcium Binding Protein Antibody (Anti-S100) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-S100 Calcium Binding Protein Antibody (Anti-S100) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 90-97% | 78-94% | 80-105% | 93-105% |
| EDTA plasma(n=5) | 87-95% | 78-96% | 98-105% | 79-90% |
| heparin plasma(n=5) | 94-101% | 95-102% | 85-93% | 78-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 5 times;
5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
6. Add 50µL Stop Solution. Read at 450nm immediately.
| Magazine | Citations |
| Brain Research | Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats ScienceDirect: S0006899311008663 |
| J Exp Neurosci | A New Technique for Collection of Cerebrospinal Fluid in Rat Pups PubMed: 26056488 |
| PLoS One | Regulation of Nutritional Metabolism in Transition Dairy Cows: Energy Homeostasis and Health in Response to Post-Ruminal Choline and Methionine pubmed:27501393 |
| brain research | Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling. pubmed:28238669 |
| КиберЛенинка | Levels of neurotropic autoantibodies in patients with schizophrenia article:n |
| Biomed Research International | Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway Pubmed:29770336 |
| Metabolic Brain Disease | Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms Pubmed: 30421246 |
| ВОЗМОЖНОСТЬ ПРОГНОЗИРОВАНИЯ ОСТРОЙ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В НИЖНЕЙ ЧАСТИ СПИНЫ С ИСПОЛЬЗОВАНИЕМ СЫВОРОТОЧНЫХ … | |
| ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС |
Share
